Lighter Jennifer, Rigaud Mona, Eduardo Roger, Peng Chia-Hui, Pollack Henry
Department of Pediatrics, New York University School of Medicine, New York, NY 10016, USA.
Pediatrics. 2009 Jan;123(1):30-7. doi: 10.1542/peds.2007-3618.
The QuantiFERON-TB Gold test was the first blood test to be approved for the diagnosis of latent tuberculosis infection. Although it has been shown to be sensitive and specific in adults, limited data on its performance in children are available.
This was a prospective study of children receiving health care in New York, New York. Each child was assessed for risk factors for Mycobacterium tuberculosis infection, underwent tuberculin skin testing, and had a QuantiFERON-TB Gold In-Tube test performed. The concordance between tuberculin skin test and QuantiFERON-TB Gold In-Tube test results was calculated, and the results were analyzed according to the likelihood of exposure to M tuberculosis.
Data for 207 children with valid tuberculin skin test and QuantiFERON-TB Gold In-Tube test results were analyzed. There was excellent correlation between negative tuberculin skin test results and negative QuantiFERON-TB Gold In-Tube test results; however, only 23% of children with positive tuberculin skin test results had positive QuantiFERON-TB Gold In-Tube test results. Positive QuantiFERON-TB Gold In-Tube test results were associated with increased likelihood of M tuberculosis exposure, and interferon gamma levels were higher in children with known recent exposure to M tuberculosis, compared with children with older exposure histories. Younger children produced lower interferon gamma levels in response to the mitogen (phytohemagglutinin) control used in the QuantiFERON-TB Gold In-Tube test, but indeterminant results were low for children of all ages. Performance characteristics were similar across all age groups.
The QuantiFERON-TB Gold In-Tube test is a specific test for M tuberculosis exposure in children, with performance characteristics similar to those for adults residing in regions with low levels of endemic disease. Concerns about test sensitivity, especially for children <2 years of age, will require additional prospective long-term evaluation.
结核感染T细胞检测(QuantiFERON-TB Gold试验)是首个被批准用于诊断潜伏性结核感染的血液检测方法。尽管该方法在成人中已被证明具有敏感性和特异性,但关于其在儿童中的检测性能的数据有限。
这是一项针对纽约市接受医疗保健的儿童的前瞻性研究。对每个儿童评估结核分枝杆菌感染的危险因素,进行结核菌素皮肤试验,并进行结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)。计算结核菌素皮肤试验和结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)结果之间的一致性,并根据接触结核分枝杆菌的可能性对结果进行分析。
对207名结核菌素皮肤试验和结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)结果有效的儿童数据进行了分析。结核菌素皮肤试验结果阴性与结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)结果阴性之间存在极好的相关性;然而,结核菌素皮肤试验结果阳性的儿童中只有23%的结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)结果为阳性。结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)结果阳性与接触结核分枝杆菌的可能性增加相关,与有既往接触史的儿童相比,近期已知接触结核分枝杆菌的儿童中干扰素γ水平更高。年龄较小的儿童对结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)中使用的丝裂原(植物血凝素)对照产生的干扰素γ水平较低,但各年龄段儿童的不确定结果比例较低。所有年龄组的检测性能特征相似。
结核感染T细胞检测(QuantiFERON-TB Gold In-Tube试验)是一种检测儿童是否接触结核分枝杆菌的特异性检测方法,其检测性能特征与居住在地方病低发地区的成人相似。对于检测敏感性的担忧,尤其是对于2岁以下的儿童,需要进行额外的前瞻性长期评估。